Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
TH-302 in Combination With Bevacizumab for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Pembrolizumab +/- Bevacizumab for Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab Therapy for Brain Arteriovenous Malformation
- Status
- COMPLETED
- Phase
- PHASE1
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1